Evaluating the Efficacy and Safety of QL0911 in Chemotherapy- Induced Thrombocytopenia
Status:
Completed
Trial end date:
2021-09-10
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of QL0911 in Chemotherapy- Induced Thrombocytopenia.
Thrombocytopenia is a low number of platelets in the blood. Sometimes, thrombocytopenia is a
side effect of chemotherapy.